Department of Pathology, Ohio State University, Columbus, Ohio 43201, USA.
Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43210, USA.
J Cell Sci. 2022 Jun 1;135(11). doi: 10.1242/jcs.259617. Epub 2022 May 31.
We have previously demonstrated significant upregulation of dopamine D2 (DAD2) receptor (DRD2) expression on tumor endothelial cells. The dopamine D2 receptors, upon activation, inhibit the proangiogenic actions of vascular endothelial growth factor-A (VEGF-A, also known as vascular permeability factor). Interestingly, unlike tumor endothelial cells, normal endothelial cells exhibit very low to no expression of dopamine D2 receptors. Here, for the first time, we demonstrate that through paracrine signaling, VEGF-A can control the expression of dopamine D2 receptors on endothelial cells via Krüppel-like factor 11 (KLF11)-extracellular signal-regulated kinase (ERK) 1/2 pathway. These results thus reveal a novel bidirectional communication between VEGF-A and DAD2 receptors.
我们之前已经证明肿瘤内皮细胞上多巴胺 D2(DAD2)受体(DRD2)的表达显著上调。多巴胺 D2 受体激活后,可抑制血管内皮生长因子-A(VEGF-A,也称为血管通透性因子)的促血管生成作用。有趣的是,与肿瘤内皮细胞不同,正常内皮细胞表达的多巴胺 D2 受体非常低或没有。在这里,我们首次证明,通过旁分泌信号,VEGF-A 可以通过 Krüppel 样因子 11(KLF11)-细胞外信号调节激酶(ERK)1/2 途径控制内皮细胞上多巴胺 D2 受体的表达。这些结果揭示了 VEGF-A 和 DAD2 受体之间的一种新的双向通讯。